F.D.A. Approves the First New Schizophrenia Drug in Decades – The New York Times

F.D.A. Approves the First New Schizophrenia Drug in Decades The New York Times
FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades CNBC
First Novel Schizophrenia Treatment in Decades Gains FDA Approval The Wall Street Journal
FDA eyes first schizophrenia drug shift in decades Axios
FDA approves new type of antipsychotic drug, a potential ‘game-changer’ The Washington Post